日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in women with HER2(+) breast cancer: TBCRC049 phase 2 study results

Tucatinib-trastuzumab-capecitabine治疗HER2(+)乳腺癌女性软脑膜转移:TBCRC049 II期研究结果

Murthy, Rashmi K; O'Brien, Barbara J; Berry, Donald A; Singareeka-Raghavendra, Akshara; Monroe, Maria Gule; Johnson, Jason; White, Jason; Schwartz-Gomez, Jill; Topletz-Erickson, Ariel; Lobbous, Mina; Riley, Kristen; Melisko, Michelle; Morikawa, Aki; Ferguson, Sherise D; de Groot, John F; Krop, Ian E; Valero, Vicente; Rimawi, Mothaffar F; Wolff, Antonio C; Tripathy, Debu; Lin, Nancy U; Stringer-Reasor, Erica M

TBCRC 035: randomized phase II pharmacodynamic study of standard and reduced-dose palbociclib with endocrine therapy in hormone receptor (HR)-positive previously treated metastatic breast cancer

TBCRC 035:一项随机 II 期药效学研究,评估标准剂量和减量帕博西尼联合内分泌治疗在激素受体 (HR) 阳性、既往接受过治疗的转移性乳腺癌患者中的疗效

Jacob, S; Mayer, E L; Kacik, N; Storniolo, A M; Isaacs, C; Mayer, I; Stearns, V; Nanda, R; Nangia, J; Chien, A J; Moasser, M; Melisko, M; Wabl, C; Muzikansky, A; Geradts, J; Dillon, D A; Park, B H; Krop, I; Wolff, A C; Kochupurakkal, B; Shapiro, G I; Rugo, H S

Detection of actionable mutations in the cerebrospinal fluid and concordance/discordance with extracranial mutations in patients with metastatic breast cancer and leptomeningeal disease

检测脑脊液中可靶向突变及其与转移性乳腺癌和软脑膜疾病患者颅外突变的一致性/不一致性

Huppert, Laura A; Fisch, Samantha; Her, Lindy; Hodgdon, Christine; Brain, Susie; Simmons, Carol; Lai, Andrew R; Malevanchik, Lev; Balassanian, Ronald; Vasudevan, Harish N; Morshed, Ramin; Braunstein, Steve; Boreta, Lauren; Majure, Melanie; Chien, A Jo; Rugo, Hope S; Magbanua, Mark Jesus M; Melisko, Michelle E

OPERA: a phase II study of DHP107 (oral paclitaxel) versus intravenous paclitaxel in patients with HER2-negative recurrent or metastatic breast cancer

OPERA:一项比较DHP107(口服紫杉醇)与静脉注射紫杉醇治疗HER2阴性复发或转移性乳腺癌患者的II期研究

Rugo, Hope S; Pluard, T J; Sharma, P; Melisko, M; Al-Jazayrly, G; Ji, Y; Vidula, N; Ellerton, J; Smakal, M; Zimovjanova, M; Weng, D

Identification of Early Symptoms Associated with Subsequent Immune-related Adverse Events in the I-SPY clinical trial

在 I-SPY 临床试验中识别与后续免疫相关不良事件相关的早期症状

Basu, Amrita; Umashankar, Saumya; Melisko, Michelle; Roy, Ritu; Yau, Christina; Pusztai, Lajos; Chien, A Jo; Liu, Minetta; Han, Hyo; Soliman, Hatem; Isaacs, Claudine; Shatsky, Rebecca; Stringer-Reasor, Erica; Robinson, Patricia; Yeung, Kay; Kalinsky, Kevin; Thomas, Alexandra; Philip, Errol; Musthafa, Mina; Hirst, Gillian; Asare, Adam; DeMichele, Angela; Van't Veer, Laura; Yee, Douglas; Hylton, Nola; Olshen, Adam; Perlmutter, Jane; Cohen, Ronald N; Quandt, Zoe; Esserman, Laura; Hershman, Dawn; Rugo, Hope; Nanda, Rita

Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC)

一项多中心回顾性队列研究,探讨抗体药物偶联物(ADC)曲妥珠单抗德鲁西替康(T-DXd)和沙妥珠单抗戈维替康(SG)在HER2低表达转移性乳腺癌(MBC)患者中的序贯应用。

Huppert, Laura A; Mahtani, Reshma; Fisch, Samantha; Dempsey, Naomi; Premji, Sarah; Raimonde, Angelina; Jacob, Saya; Quintal, Laura; Melisko, Michelle; Chien, Jo; Sandoval, Ana; Carcas, Lauren; Ahluwalia, Manmeet; Harpalani, Natasha; Hoppenworth, Jenna; Blaes, Anne; Blum, Kelly; Kim, Mi-Ok; Idossa, Dame; Rao, Ruta; Giridhar, Karthik V; Rugo, Hope S

Phase Ib study of intratumoral talimogene laherparepvec (T-VEC) in combination with chemotherapy or endocrine therapy in patients with advanced HER2-negative breast cancer

一项针对晚期 HER2 阴性乳腺癌患者的 Ib 期研究,评估肿瘤内注射 talimogene laherparepvec (T-VEC) 联合化疗或内分泌治疗的疗效。

Huppert, Laura A; Gliwa, Amelia S; Tait, Madeline; Quintal, Laura; Starzinski, Stephanie; Cheung, Alexander; Moasser, Mark; Majure, Melanie; Melisko, Michelle; Munster, Pamela; Rugo, Hope S; Campbell, Michael; Fong, Lawrence; Chien, A Jo

Multi-institutional analysis of incidence and risks for late-onset immune toxicity in breast cancer

乳腺癌迟发性免疫毒性发生率和风险的多中心分析

Jacob, Saya; Fisch, Samantha; Face, Carolyne; Blum, Kelly; Chengappa, Madhuri; Chaudhry, Saliha; LeVee, Alexis; Baclig, Nikita V; Soliman, Andrew; Huppert, Laura A; Quandt, Zoe; Quintal, Laura; Idossa, Dame; Melisko, Michelle; Chien, A Jo; Kim, Mi-Ok; Mortimer, Joanne; McCann, Kelly; Blaes, Anne; Rugo, Hope S

Evaluating survival trends over time in patients with metastatic breast cancer and brain metastases: a single center retrospective cohort study

评估转移性乳腺癌和脑转移患者的生存趋势:一项单中心回顾性队列研究

Krasnow, Nira A; Jayaraj, Michelle; Salans, Mia; Kuwahara, Kelsey; Zhou, Maggie H; Fisch, Samantha; Boreta, Lauren; Braunstein, Steve E; Aghi, Manish K; Batra-Sharma, Hemali; Majure, Melanie; Chien, Jo; Rugo, Hope S; Morshed, Ramin A; Vasudevan, Harish N; Melisko, Michelle E; Huppert, Laura A

System-Level Transformations to Increase Patient Participation in Clinical Trials

通过系统层面的变革来提高患者参与临床试验的积极性

Caston, Nicole E; Deng, Luqin; Williams, Courtney P; Levitan, Emily B; Azuero, Andres; Griffin, Russell; Smith, Karen L; Wolff, Antonio C; Melisko, Michelle E; Shinn, Eileen H; Gallagher, Kathleen; Angove, Rebekah; Wheeler, Stephanie B; Rocque, Gabrielle B